retatrutide obesity triple hormone receptor agonist Agonism Based Therapies for | Current Cardiovascular Risk Reports Triple-Hormone-Receptor Agonist Retatrutide for... :

DEXA substudies across the class suggest somewhere between a quarter and a third of the loss can be lean mass, and the early retatrutide figure sits at the high end of that range, with the usual caveats about what DEXA actually measures

Consuming alcohol while taking a GLP-1 could exacerbate the fluid loss due to these GI side effects

Glucagon-like peptide-1 receptor agonists (GLP-1 RAs), initially developed for glycemic control among people with T2DM, have gained increasing attention for their broader metabolic and cardiovascular benefits

Participants using semaglutide showed LDL cholesterol reductions averaging 515%, with more pronounced improvements in those who achieved greater weight loss

doi: 10.1016/j.jacc.2008.10.033

EWY, the iShares MSCI South Korean ETF, has risen 211% over the last year, primarily driven by its roughly 50% combined weight to Samsung and SK Hynix